碱基编辑消除CaMKIIδ自磷酸化改善小鼠心衰生存与心功能
研究利用CRISPR-Cas9腺嘌呤碱基编辑技术消除CaMKIIδ自磷酸化位点,在生殖系构建磷酸化抵抗小鼠并接受严重横向主动脉缩窄。结果显示编辑小鼠死亡率仅11%,野生型为65%,且心功能、基因表达、凋亡和纤维化均改善,人iPSC编辑特异性高。
要点
- 碱基编辑消除CaMKIIδ自磷酸化可显著降低心衰小鼠死亡率并改善心功能。
- 编辑小鼠避免心衰相关基因表达异常、心肌凋亡和纤维化。
- 对CaMKIIδ编辑特异性较其他亚型高>2000倍,具安全性特征。
核心结论
- 腺嘌呤碱基编辑消除CaMKIIδ自磷酸化可能为人类心脏病提供广泛治疗概念。
研究设计与样本
- 使用CRISPR-Cas9腺嘌呤碱基编辑构建生殖系CaMKIIδ磷酸化抵抗突变小鼠,并施加严重横向主动脉缩窄心衰模型。
- 通过超声心动图、RNA测序、TUNEL染色和组织学评估心功能、转录变化、凋亡和纤维化。
- 用深度扩增子测序评估CaMKIIδ基因编辑特异性,用Fura-2负载心肌细胞荧光显微镜分析钙稳态。
主要发现
- 严重横向主动脉缩窄术后2周内,65%野生型小鼠死亡,存活者心功能显著受损。
- CaMKIIδ磷酸化抵抗基因编辑小鼠死亡率仅11%,心功能显著改善。
- 编辑小鼠免受心衰相关心脏基因表达异常、心肌凋亡及后续纤维化。
- 对CaMKIIδ编辑特异性较其他CaMKII亚型高>2000倍。
- 慢性β肾上腺素能应激下,野生型心肌细胞钙瞬变受损且心律失常频率增加,而CaMKIIδ编辑心肌细胞受保护。
临床怎么用
- 碱基编辑靶向CaMKIIδ自磷酸化位点可能成为心衰的广谱治疗策略,但尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular diseases are the main cause of worldwide morbidity and mortality, highlighting the need for new therapeutic strategies. Autophosphorylation and subsequent overactivation of the cardiac stress-responsive enzyme CaMKIIδ (Ca2+/calmodulin-dependent protein kinase IIδ) serves as a central driver of multiple cardiac disorders. METHODS: To develop a comprehensive therapy for heart failure, we used CRISPR-Cas9 adenine base editing to ablate the autophosphorylation site of CaMKIIδ. We generated mice harboring a phospho-resistant CaMKIIδ mutation in the germline and subjected these mice to severe transverse aortic constriction, a model for heart failure. Cardiac function, transcriptional changes, apoptosis, and fibrosis were assessed by echocardiography, RNA sequencing, terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and standard histology, respectively. Specificity toward CaMKIIδ gene editing was assessed using deep amplicon sequencing. Cellular Ca2+ homeostasis was analyzed using epifluorescence microscopy in Fura-2-loaded cardiomyocytes. RESULTS: Within 2 weeks after severe transverse aortic constriction surgery, 65% of all wild-type mice died, and the surviving mice showed dramatically impaired cardiac function. In contrast to wild-type mice, CaMKIIδ phospho-resistant gene-edited mice showed a mortality rate of only 11% and exhibited substantially improved cardiac function after severe transverse aortic constriction. Moreover, CaMKIIδ phospho-resistant mice were protected from heart failure-related aberrant changes in cardiac gene expression, myocardial apoptosis, and subsequent fibrosis, which were observed in wild-type mice after severe transverse aortic constriction. On the basis of identical mouse and human genome sequences encoding the autophosphorylation site of CaMKIIδ, we deployed the same editing strategy to modify this pathogenic site in human induced pluripotent stem cells. It is notable that we detected a >2000-fold increased specificity for editing of CaMKIIδ compared with other CaMKII isoforms, which is an important safety feature. While wild-type cardiomyocytes showed impaired Ca2+ transients and an increased frequency of arrhythmias after chronic β-adrenergic stress, CaMKIIδ-edited cardiomyocytes were protected from these adverse responses. CONCLUSIONS: Ablation of CaMKIIδ autophosphorylation by adenine base editing may offer a potential broad-based therapeutic concept for human cardiac disease.
引用
- Lebek, Caravia, Chemello, et al. Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice. Circulation. 2023. PMID: 37712250. doi:10.1161/CIRCULATIONAHA.123.065117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。